EP Patent

EP2089361A2 — Inhibitors of sodium glucose co-transporter 2 and methods of their use

Assigned to Lexicon Pharmaceuticals Inc · Expires 2009-08-19 · 17y expired

What this patent protects

Compounds and pharmaceutical compositions comprising them are disclosed that may be useful for the treatment of diseases and disorders such as diabetes and obesity.

USPTO Abstract

Compounds and pharmaceutical compositions comprising them are disclosed that may be useful for the treatment of diseases and disorders such as diabetes and obesity.

Drugs covered by this patent

Patent Metadata

Patent number
EP2089361A2
Jurisdiction
EP
Classification
—
Expires
2009-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Lexicon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.